Search for Clinical Trial Results

Sponsored By

Retinal Neovascularization - 16 Studies Found

Status Study
Completed Study Name: Squalamine for the Treatment in Proliferative Diabetic Retinopathy
Condition: Retinal Neovascularization
Date: 2013-01-14
Interventions: Drug: Squalamine Lactate ophthalmic solution 0.2% Patients will start with Squalamine one drop twice dai
Recruiting Study Name: Study of the Modification of the Retinal Nerve Fiber Layer in Patients Treated With Intravitreous Injection of Anti-VEGF
Condition: Retinal Neovascularization
Date: 2016-08-16
Interventions: Device: Gonioscopy Study of the trabecular structure by gonioscopy
Completed Study Name: Intravitreal Avastin in Proliferative Retinopathies
Condition: Retinal Neovascularization
Date: 2007-11-26
Interventions: Drug: Avastin 2,5 mg Avastin intravitreal injections every 4 weeks, 6 months consecutively
Terminated Study Name: Clinical Research on Retinal Neovascularization of Diabetic Retinopathy
Condition:
  • The Mechanism of Retinal Neovascularization of Diabetic
  • Retinop
    Date: 2010-10-26
    Interventions: Genetic: genetic analyzer
Completed Study Name: Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy
Condition:
  • Diabetic Retinopathy
  • Retinal Neovascularization

Date: 2010-04-09
Interventions:
  • Drug: Ranibizumab Ranibizumab

Completed Study Name: Ranibizumab in Diabetic Vitrectomy
Condition:
  • Diabetic Retinopathy
  • Retinal Neovascularisation

Date: 2011-03-01
Interventions:
  • Drug: Ranibizumab Intravitreal
Completed Study Name: Krypton-Argon Regression of Neovascularization Study (KARNS)
Condition:
  • Diabetic Retinopathy
  • Retinal Neovascularization
  • Date: 1999-09-23
    Interventions:
    • Procedure: Blue-Green Argon Laser Treatment
Recruiting Study Name: Selective Retinal Pigment Epithelium Laser Therapy for Macular Disease of the Retina
Condition:
  • Macular Edema
  • Central Serous Chorioretinopathy
  • Retinal Vei
    Date: 2014-03-06
    Interventions: Device: Selective retinal pigment epithelium laser therapy using the R:GEN Laser System Patients receive
Recruiting Study Name: Safety and Efficacy Study of rAAV.sFlt-1 in Patients With Exudative Age-Related Macular Degeneration
Condition:
  • Macular Degeneration
  • Age-related Maculopathies
  • Age-related
    Date: 2011-12-14
    Interventions:
    • Biological: rAAV.sFlt-1 1 x 10
Active, not recruiting Study Name: Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
Condition:
  • Macular Degeneration
  • Age-Related Maculopathies
  • Age-Related
    Date: 2009-12-02
    Interventions:
    • Biological: AAV2-sFLT01 2 x 10
Next >>>